Hajj, A.; Halepian, L.; Osta, N.E.; Chahine, G.; Kattan, J.; Rabbaa Khabbaz, L.
OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings. Int. J. Mol. Sci. 2017, 18, 669.
https://doi.org/10.3390/ijms18040669
AMA Style
Hajj A, Halepian L, Osta NE, Chahine G, Kattan J, Rabbaa Khabbaz L.
OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings. International Journal of Molecular Sciences. 2017; 18(4):669.
https://doi.org/10.3390/ijms18040669
Chicago/Turabian Style
Hajj, Aline, Lucine Halepian, Nada El Osta, Georges Chahine, Joseph Kattan, and Lydia Rabbaa Khabbaz.
2017. "OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings" International Journal of Molecular Sciences 18, no. 4: 669.
https://doi.org/10.3390/ijms18040669
APA Style
Hajj, A., Halepian, L., Osta, N. E., Chahine, G., Kattan, J., & Rabbaa Khabbaz, L.
(2017). OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings. International Journal of Molecular Sciences, 18(4), 669.
https://doi.org/10.3390/ijms18040669